Clariant is expanding production capacity for its isethionates derivatives - Hostapon SCI - mild surfactants to support the increasing shift by personal care formulators and brands towards using mild surfactants to differentiate applications. It also supports the growing consumer trend for hygiene products. The investment at facilities in Europe and the USA will bring additional capacity on stream during Q1 2021.
“As one of the leading company for specialty chemicals in personal care, Clariant continues to invest and support the latest trends in the sector. Mild surfactants are a growing sector driven by consumers seeking new mildness claims, invaluable in helping formulators to answer needs for mild cleansing hygiene, sensitive skin solutions, solid formats and more natural ingredients,” comments Christian Vang, Global Head of Business Unit Industrial & Consumer Specialties.
As a global expansion, the investment targets capacity increase and general modernization of current facilities at the Mount Holly (USA) and Tarragona (Spain) manufacturing sites. The general asset modernization will optimize energy consumption and also aggregate options for new SI grades (different Carbon-chains).